Who Owns WellCare?
WellCare is owned by Centene Corporation (NYSE: CNC), a publicly traded American managed care company headquartered in St. Louis, Missouri. Centene acquired WellCare Health Plans, Inc. in January 2020 for approximately $17.3 billion, making it one of the largest managed care acquisitions in U.S. history. Following the acquisition, Centene consolidated its Medicare Advantage and prescription drug plan offerings under the WellCare brand nationally. WellCare was originally founded in 1985 in Tampa, Florida, and had been publicly traded before the Centene acquisition.
Parent Company
Centene Corporation
Acquired
2020
Status
Publicly Traded
Headquarters
Tampa, Florida, USA
Who Owns WellCare?
- Parent Company: Centene Corporation
- Ownership Type: Wholly owned
- Acquisition Year: 2020
- Company Type: Publicly Traded
- Stock Ticker: NYSE: CNC
| Brand | Parent Company | Ownership Type |
|---|---|---|
| WellCare | Centene Corporation | Wholly owned |
History of WellCare
- Founded: 1985
- Founders: Todd Farha (early leadership; company founded 1985 in Tampa)
- Acquired by Centene Corporation: 2020
WellCare was founded in 1985 in Tampa, Florida, as a managed care organization focused on serving Florida's government-sponsored health program populations. The company was established to provide healthcare coverage and care coordination services to Medicaid beneficiaries, a population that private managed care organizations were increasingly being contracted to serve as states sought to control Medicaid costs through managed care arrangements.
Throughout the late 1980s and 1990s, WellCare expanded its presence in Florida's Medicaid managed care market, developing expertise in serving low-income populations and building relationships with healthcare providers across the state. The company grew its membership base and expanded its service offerings to include Medicare managed care plans as the Medicare+Choice program (later renamed Medicare Advantage) expanded in the late 1990s.
WellCare went public in 2004 through an initial public offering on the NASDAQ, raising capital to fund its continued expansion. The company subsequently transferred its listing to the New York Stock Exchange. WellCare's public market debut reflected the growing investor interest in managed care companies serving government-sponsored health programs, which offered relatively predictable revenue streams from government contracts.
In 2007, WellCare faced a significant regulatory crisis when federal and state investigators raided the company's headquarters in connection with an investigation into alleged overbilling of Florida's Medicaid and Medicare programs. The investigation resulted in substantial legal settlements and management changes. The company paid approximately $218 million to resolve federal and state fraud allegations in 2012. The regulatory crisis significantly damaged WellCare's reputation and financial position, requiring the company to rebuild its compliance infrastructure and management team.
Following the regulatory crisis, WellCare undertook a significant restructuring and compliance improvement program. The company rebuilt its management team, strengthened its compliance and audit functions, and refocused its business on sustainable growth in government-sponsored health programs. Under new leadership, WellCare returned to growth and expanded its geographic footprint beyond Florida.
By the mid-2010s, WellCare had successfully rebuilt its business and was growing its Medicaid and Medicare Advantage membership across multiple states. The company expanded through both organic growth and acquisitions, including the purchase of Universal American's Medicare Advantage business in 2014 and the acquisition of Care1st Health Plan in 2015, which expanded WellCare's presence in Arizona and California.
In March 2019, Centene Corporation announced that it would acquire WellCare Health Plans in a cash and stock transaction valued at approximately $17.3 billion. The acquisition was the largest in Centene's history and one of the largest managed care transactions in U.S. history. The deal was intended to create a combined company with approximately 22 million members and significantly enhanced capabilities in both Medicaid and Medicare managed care.
The acquisition received regulatory approval from state insurance regulators and the Department of Justice, subject to divestitures of certain overlapping health plan operations. Centene divested its Illinois Medicaid and Medicare Advantage plans, and WellCare divested its Missouri Medicaid and Medicare Advantage plans and its Nebraska Medicaid plan, to address antitrust concerns. The transaction closed on January 23, 2020.
Following the acquisition, Centene announced that it would use the WellCare brand as its national Medicare Advantage and prescription drug plan brand, consolidating Medicare offerings from multiple Centene subsidiaries under the WellCare name. This decision gave WellCare a significantly expanded national presence, extending the brand beyond its Florida origins to serve Medicare beneficiaries across the United States.
About Centene Corporation
Centene Corporation operates through two main business segments: Managed Care and Specialty Services. The Managed Care segment provides health insurance coverage through Medicaid, Medicare Advantage, and marketplace health plans. The company serves millions of members across multiple states with locally branded health plans.
The Specialty Services segment includes pharmacy benefits management, behavioral health services, care management, and other healthcare services. Centene's specialty services complement its managed care offerings and provide integrated healthcare solutions for complex populations.
Centene's business model focuses on government-sponsored healthcare programs, making the company highly dependent on public policy and government funding. The company operates health plans under various local brand names, maintaining a community-focused approach while leveraging national scale and expertise.
Centene employs approximately 74,000 people nationwide and generates annual revenues exceeding $140 billion. The company serves as a critical intermediary between government healthcare programs and healthcare providers, ensuring access to care for vulnerable populations.
- Founded: 1984
- Headquarters: St. Louis, Missouri, USA
- Company Type: Publicly Traded
- Stock: NYSE: CNC
- Revenue: approximately $166.0 billion (FY2024)
- Employees: Approximately 75,000
Where Is WellCare Made / Based?
- Headquarters: Tampa, Florida, USA
- Manufacturing / Operations: United States
WellCare Sustainability & Ethics
WellCare operates under Centene Corporation's comprehensive sustainability framework, which encompasses environmental responsibility, ethical healthcare delivery, and social impact in the managed care industry. As a Medicare Advantage and prescription drug plan provider, WellCare's sustainability efforts focus on healthcare accessibility, environmental stewardship, ethical governance, and community health improvement while maintaining its position as a leading government-sponsored health plan provider.
Healthcare Access and Equity Initiatives: WellCare maintains comprehensive programs to improve healthcare access for underserved populations, including Medicare beneficiaries with complex health needs and limited resources. The company's health equity initiatives focus on reducing healthcare disparities through culturally competent care, language access services, and targeted outreach to vulnerable populations. WellCare's care coordination programs help members navigate complex healthcare systems and access necessary medical services.
Sustainable Healthcare Operations: WellCare implements environmental sustainability practices across its operations, including energy-efficient office facilities, paperless administrative processes, and telehealth services that reduce transportation-related emissions. The company's digital health initiatives and remote care management programs support environmental sustainability while improving healthcare access and convenience for Medicare beneficiaries.
Ethical Governance and Compliance: WellCare maintains comprehensive ethical governance standards following its 2007 regulatory crisis, implementing robust compliance programs, audit functions, and ethical business practices. The company's commitment to ethical healthcare delivery includes transparent communication with members, providers, and regulators, along with rigorous adherence to healthcare regulations and anti-fraud measures.
Community Health Investment: WellCare invests in community health programs that address social determinants of health, including nutrition assistance, transportation services, and housing support for Medicare beneficiaries. The company's community health initiatives partner with local organizations to improve health outcomes and reduce healthcare costs through preventive care and social support services.
Environmental Compliance and Healthcare Facilities: WellCare maintains environmental compliance across its office facilities and healthcare operations, implementing energy-efficient systems, waste reduction programs, and sustainable procurement practices. The company's healthcare facility management includes environmental monitoring and compliance with healthcare industry environmental standards.
Digital Accessibility and Health Innovation: WellCare's digital health platforms and telehealth services promote environmental sustainability while expanding healthcare access for Medicare beneficiaries. The company's investment in digital health technologies reduces the need for in-person visits, lowering transportation emissions and improving healthcare convenience for elderly and disabled members.
Transparency and Corporate Responsibility: WellCare provides regular sustainability reporting through Centene's corporate responsibility programs, detailing progress toward environmental targets, health equity initiatives, and community impact programs. The company maintains transparency about its sustainability practices and challenges, enabling stakeholders to assess its progress toward responsible healthcare delivery.
Awards & Recognition
WellCare has received significant recognition for excellence in Medicare Advantage services, healthcare innovation, and community health programs, establishing itself as a leading government-sponsored health plan provider with a strong focus on member satisfaction and quality care.
Medicare Advantage Quality Recognition: WellCare has received multiple awards for high Medicare Advantage star ratings from the Centers for Medicare and Medicaid Services (CMS). The company's consistent achievement of 4-star and 5-star ratings has been acknowledged by healthcare organizations for demonstrating excellence in healthcare quality, member satisfaction, and clinical outcomes.
Healthcare Innovation Awards: WellCare's development of innovative care management programs and digital health solutions has received recognition from healthcare technology organizations and managed care industry publications. The company's telehealth initiatives and remote care management programs have been acknowledged for advancing healthcare accessibility and convenience for Medicare beneficiaries.
Community Health Program Recognition: WellCare's community health investment programs and social determinants of health initiatives have received acknowledgment from public health organizations and community advocacy groups. The company's partnerships with local organizations to address healthcare access barriers have been recognized for improving community health outcomes.
Member Satisfaction Excellence: WellCare has received recognition from member satisfaction surveys and healthcare consumer organizations for high member satisfaction scores and positive member experiences. The company's focus on personalized care coordination and member support services has resulted in consistent high ratings and positive member feedback.
Care Management Innovation: WellCare's care coordination and disease management programs have received recognition from healthcare quality organizations for improving health outcomes and reducing healthcare costs for Medicare beneficiaries with chronic conditions. The company's integrated care management approach has been acknowledged as a best practice in managed care.
Diversity and Inclusion Recognition: WellCare's commitment to diversity, equity, and inclusion in healthcare delivery has received acknowledgment from healthcare organizations and diversity advocacy groups. The company's culturally competent care programs and language access services have been recognized for improving healthcare access for diverse populations.
Corporate Social Responsibility Awards: WellCare's community investment programs and social responsibility initiatives have received recognition from corporate social responsibility organizations for demonstrating commitment to community health improvement and sustainable healthcare practices.
Technology and Digital Health Recognition: WellCare's digital health platforms and telehealth services have received recognition from healthcare technology organizations for innovation in healthcare delivery and expanding access to care for Medicare beneficiaries through digital solutions.
WellCare Recalls & Controversies
WellCare has faced significant challenges and controversies throughout its history, primarily related to regulatory compliance issues, legal settlements, and competitive pressures in the managed care industry, though the company has successfully rebuilt its reputation and operations following major challenges.
2007 Regulatory Crisis and Fraud Investigation: The most significant controversy in WellCare's history occurred in 2007 when federal and state investigators raided the company's Tampa headquarters in connection with an investigation into alleged overbilling of Florida's Medicaid and Medicare programs. The investigation revealed systematic billing irregularities and fraudulent claims practices that resulted in substantial legal and financial consequences for the company.
$218 Million Legal Settlement (2012): WellCare paid approximately $218 million to resolve federal and state fraud allegations related to the 2007 investigation. The settlement included payments to resolve Medicaid and Medicare overbilling claims, along with requirements to implement comprehensive compliance reforms and monitoring programs. This settlement represented one of the largest healthcare fraud settlements of its time.
Management Changes and Corporate Restructuring: The regulatory crisis led to significant management changes, including the departure of key executives and the appointment of new leadership focused on compliance reform. WellCare undertook a comprehensive corporate restructuring to rebuild its compliance infrastructure and restore credibility with regulators and healthcare providers.
Reputational Damage and Market Impact: The fraud investigation and settlement caused significant reputational damage, affecting WellCare's relationships with healthcare providers, regulators, and members. The company faced membership declines and increased scrutiny from state insurance departments, requiring substantial effort to rebuild trust and market position.
Centene Acquisition Integration Challenges: Following the 2020 acquisition by Centene, WellCare faced integration challenges related to consolidating multiple Medicare brands under the WellCare name and aligning operations with Centene's corporate structure. These integration challenges required careful management to maintain service quality and member satisfaction during the transition.
Medicare Advantage Regulatory Compliance: WellCare operates under strict regulatory oversight from the Centers for Medicare and Medicaid Services (CMS), which sets requirements for Medicare Advantage plans including star quality ratings, benefit design standards, and network adequacy requirements. Compliance with these complex regulations creates ongoing operational challenges.
Competitive Pressures in Medicare Market: WellCare faces intense competition from larger Medicare Advantage insurers including UnitedHealthcare and Humana, which have greater scale and longer operating histories in the Medicare market. This competition creates pressure on pricing, benefit design, and provider network development.
CMS Star Rating Challenges: Medicare Advantage star quality ratings significantly impact plan reimbursement and marketing eligibility. WellCare must continuously invest in quality improvement programs to maintain high star ratings, creating operational and financial pressures related to quality measurement and reporting.
State Regulatory Oversight: As a health insurance provider, WellCare faces ongoing regulatory scrutiny from state insurance departments regarding rate filings, policy forms, and consumer protection compliance. This regulatory oversight requires significant compliance resources and creates potential for regulatory disputes.
Data Privacy and Security Concerns: WellCare handles sensitive member health information and faces ongoing challenges related to data privacy, cybersecurity, and compliance with healthcare privacy regulations including HIPAA. Data security breaches or privacy violations could result in regulatory penalties and reputational damage.
Brands Owned by Centene Corporation
- Centene Medicare - Centene Corporation's Medicare Advantage and prescription drug plan offerings, p...
- Sunshine Health - Centene Corporation's Florida-based health insurance brand providing Medicaid ma...
WellCare Ownership: Pros & Cons
Advantages
- +Centene's $17.3 billion acquisition of WellCare in 2020 created a combined company with significantly enhanced Medicare capabilities, with WellCare's established Medicare Advantage operations complementing Centene's existing Medicaid strength
- +WellCare's designation as Centene's national Medicare brand provides the brand with a significantly expanded geographic footprint, extending beyond its Florida origins to serve Medicare beneficiaries across the United States
- +WellCare's established brand recognition among Medicare beneficiaries and healthcare providers, built over decades of operation in the Medicare market, provides a competitive advantage in attracting and retaining Medicare members
- +Centene's scale and financial resources, with approximately $144.5 billion in annual revenues, provide WellCare with investment capacity for benefit design, provider network development, and technology that smaller Medicare plans cannot match
- +The growing Medicare Advantage market, with enrollment increasing as the large baby boomer generation ages into Medicare eligibility, provides WellCare with a favorable long-term growth environment
Considerations
- -WellCare's 2007 regulatory crisis, which resulted in a $218 million settlement for alleged Medicaid and Medicare overbilling, created lasting reputational damage that the brand has worked to overcome through compliance improvements and management changes
- -Medicare Advantage reimbursement rates are set by the Centers for Medicare and Medicaid Services (CMS) and are subject to annual adjustments, creating revenue uncertainty and requiring WellCare to continuously adapt its benefit design and cost management
- -Competition in the Medicare Advantage market from UnitedHealthcare, Humana, and Aetna, all of which have larger Medicare Advantage memberships and longer operating histories in the segment, creates sustained competitive pressure
- -CMS star quality ratings, which affect Medicare Advantage plan reimbursement and marketing eligibility, require continuous investment in quality improvement programs and member satisfaction
- -Centene's broader financial challenges, including pressure on Medicaid margins from state contract repricing and membership changes, could affect the investment available for WellCare's Medicare business development
Sources & Further Reading
- WellCare Official Website -
- Centene Corporation Corporate Information -
- Centene Annual Report 2024 -
- New York Stock Exchange: CNC Centene Corporation -
- Centers for Medicare and Medicaid Services -
- Medicare Advantage Program Information -
- Department of Justice WellCare Acquisition Approval -
- Florida Medicaid Managed Care Information -
- Healthcare.gov Medicare Information -
- National Committee for Quality Assurance -
- Medicare Rights Center -
- Kaiser Family Foundation Medicare Research -
- American Association of Medicare Supplement Insurance -
- Managed Care Executive Forum -
- Healthcare Compliance Association -
- Centers for Medicare and Medicaid Services Star Ratings -
- Securities and Exchange Commission (SEC) Centene Filings -
- Florida Agency for Health Care Administration -
- National Association of Insurance Commissioners -
Where to Buy
Disclosure: We may earn commission from purchases
WellCare on AmazonCompetitors to WellCare
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Elevance Health | USA | 2024 | Mass market | United states | All-ages | |
| Cvs Health | United States | 1853 | Mass market | North america | All Genders | |
| Centene | USA | 2008 | Mass market | United states | All-ages |
Learn More About Competitors
WellPoint
Owned by Elevance Health Inc.
Elevance Health's government health plan brand for Medicaid, CHIP, and Medicare in states where Anthem Blue Cross Blue Shield does not operate, rebranded from Amerigroup in January 2024.
Aetna
Owned by CVS Health
American managed care and health insurance company offering medical, dental, pharmacy, and behavioral health plans, operating as a subsidiary of CVS Health Corporation.
Sunshine Health
Owned by Centene Corporation
Centene Corporation's Florida-based health insurance brand providing Medicaid managed care, Long Term Care, Ambetter marketplace plans, and Medicare Advantage to Florida residents, and one of the largest comprehensive healthcare plans in Florida.
Competitive Analysis
Market Positioning: WellCare competes with 3 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Centene Corporation Stock Information
Jobs at Centene Corporation
Latest News About WellCare
Related Articles About WellCare
View more articles
Monthly IPO Roundup: July 2026 — June's Biggest Listings
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
Monthly M&A Roundup: June 2026 Brand Ownership Changes
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.
A Complete Guide to LVMH Brands: What Does the Luxury Giant Own?
LVMH owns 75 luxury maisons including Louis Vuitton, Dior, Tiffany, Guerlain, and Sephora. Here is the complete brand list by division, with acquisition dates and what each brand does.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Activase
Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.
Acuvue
Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.